Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.24.3
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Jan. 31, 2024
Sep. 30, 2024
Sep. 30, 2023
May 07, 2024
Jan. 08, 2024
Dec. 31, 2023
Dec. 21, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Net loss   $ 54,400,000 $ 37,600,000        
Accumulated deficit   803,965,000       $ 749,524,000  
Cash, cash equivalents, restricted cash and short-term investments   110,000,000.0          
Other receivables   $ 1,600,000       $ 2,100,000  
Unfounded exercise price per share   $ 0.0001          
Warrants exercise price             $ 9.75
Loan and Security Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to purchase shares $ 2,400,000            
Warrants exercise price $ 4.75 $ 4.07     $ 4.75    
Shares of common stock issuable upon exercise of warrants   589,681          
2024 Loan Agreement Warrants [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants exercise price       $ 4.07      
Shares of common stock issuable upon exercise of warrants       589,681      
2023 Loan Agreement Warrants [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants exercise price   $ 4.07          
Shares of common stock issuable upon exercise of warrants   589,681